Abstracts tagged "Back pain"

Abstract Number: 1871 • ACR Convergence 2020
Comparison of Work Productivity Outcomes Between Chronic Back Pain Patients with and Without a Diagnosis of Axial Spondyloarthritis After 2-Year Protocolised Follow-Up: Data from the Spondyloarthritis Caught Early Cohort
Anne Boel¹, Miranda van Lunteren², Karen Fagerli³, Roberta Ramonda⁴, Sofia Exarchou⁵, Marleen van de Sande⁶, Floris van Gaalen⁷ and Désirée van der Heijde⁸, ¹Leiden University Medical Centre, Hooge Zwaluwe, Netherlands, ²Leiden University Medical Centre, Weesp, Netherlands, ³Diakonhjemmet Hospital, Oslo, Norway, ⁴University of Padova, Padova, Italy, ⁵Rheumatology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden, Malmo, Sweden, ⁶Amsterdam UMC, AMC/University of Amsterdam, Department of Rheumatology and Clinical Immunology, Amsterdam Infection & Immunity Institute and Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, Netherlands, ⁷Leiden University Medical Center (LUMC), Leiden, Netherlands, ⁸Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: The aim of this study was to compare work-productivity and activity impairment outcomes after two-year follow-up between chronic back pain (CBP) patients with and…
Abstract Number: 1876 • ACR Convergence 2020
The Role of HLA B27 in Axial Spondyloarthritis: Prevalence and Performance as a Marker in an Argentinian Cohort
Rodrigo Garcia Salinas¹, Santiago Ruta¹, Einer Sanchez Prado¹, Jessica Torres Chichande¹, Alvaro Ruta¹, Facundo Salvatori¹ and Sebastian Magri¹, ¹Hospital Italiano La Plata, La Plata, Argentina
Background/Purpose: HLA B27 prevalence in Latin America are heterogeneous and timeless, we propose to estimate the prevalence of HLA B27 in an Argentinian cohort of…
Abstract Number: 0317 • ACR Convergence 2020
Axial Involvement in Psoriatic Arthritis in a Comprehensive Rapid Diagnosis Program (Reuma-check PsA). Analysis of Its Characteristics
Rodrigo Garcia Salinas¹, Santiago Ruta², Jessica Torres Chichande¹, Einer Sanchez Prado¹, Facundo Salvatori¹ and Sebastian Magri¹, ¹Hospital Italiano La Plata, La Plata, Argentina, ²Hospital Italiano La Plata, Buenos Aires, Argentina
Background/Purpose: To date, there is no consensus that allows an appropriate definition of axial involvement in PsA, that ranges between 25 to 70%. To estimate…
Abstract Number: 1894 • ACR Convergence 2020
Use of Facebook and Electronic Patient Portal to Identify Axial Spondyloarthritis in Patients with Chronic Back Pain
Yuliya Afinogenova¹, Swetha Alexander², Andrew Haims³ and Abhijeet Danve⁴, ¹Yale University, Orange, CT, ²University of Connecticut, New Haven, ³Yale University, New Haven, CT, ⁴Yale University, Rocky Hill, CT
Background/Purpose: Delay in diagnosis of Axial Spondyloarthritis (axSpA) remains a significant unmet need and can be partially attributed to lack of timely rheumatology referral. Current…
Abstract Number: 0344 • ACR Convergence 2020
Use of the BASDAI in Psoriatic Arthritis Patients with and Without Axial Disease
Soumya Reddy¹, M. Elaine Husni², Jose Scher³, Ethan Craig⁴, Alexis Ogdie⁴ and Jessica Walsh⁵, ¹NYU School of Medicine, New York, NY, ²Cleveland Clinic, Cleveland, OH, ³NYU School of Medicine, New York City, ⁴University of Pennsylvania, Philadelphia, PA, ⁵University of Utah School of Medicine, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, UT
Background/Purpose: The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is increasingly being used to assess the activity of axial disease in patients with psoriatic arthritis…
Abstract Number: 0505 • ACR Convergence 2020
Secukinumab Provides Sustained Improvements in Clinical and Imaging Outcomes in Patients with Psoriatic Arthritis and Axial Manifestations: Results from the MAXIMISE Trial
Xenofon Baraliakos¹, Laure Gossec², Effie Pournara³, Slawomir Jeka⁴, Ricardo Blanco⁵, Salvatore D'Angelo⁶, Georg Schett⁷, Barbara Schulz³, Michael Rissler³, Dermot Whyms⁸, Chiara Perella³ and Laura Coates⁹, ¹Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, ²Sorbonne Université and Hôpital Universitaire Pitié Salpêtrière, Paris, France, ³Novartis Pharma AG, Basel, Switzerland, ⁴2nd Univ Hospital, CM UMK, Bydgoszcz, Poland, ⁵Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, ⁶Rheumatology Department of Lucania and Rheumatology Institute of Lucania (IRel), San Carlo Hospital of Potenza, Potenza, Italy, ⁷Friedrich-Alexander-Universität Erlangen- Nuremberg, Erlangen, Germany, ⁸Novartis Ireland Limited, Dublin, Ireland, ⁹University of Oxford, Oxford, United Kingdom
Background/Purpose: Axial disease may affect up to 25–70% of psoriatic arthritis (PsA) patients, depending on the definition used. Current evidence on efficacy of biologics in…
Abstract Number: 0681 • ACR Convergence 2020
Gout and Serum Urate Levels Are Associated with Lumbar Spine Monosodium Urate Deposition and Chronic Low Back Pain: A Dual-Energy CT Study
Michael Toprover¹, Michael Mechlin², Anastasia Slobodnick³, Virginia Pike⁴, Cheongeun Oh⁵, Claudine Davis², Theodore Fields⁶, Fabio Becce⁷ and Michael Pillinger⁸, ¹New York University Langone Health, New York, NY, ²NYU Langone Health, New York, NY, ³Stamford Health Medical Group, Stamford, CT, ⁴NYU Langone Health, Brooklyn, NY, ⁵NYU Grossman School of Medicine, New York, ⁶Hospital for Special Surgery, New York, NY, ⁷Lausanne University, Lausanne, Switzerland, ⁸New York University Grossman School of Medicine, New York,, NY
Background/Purpose: Spinal gout is reported as a rare event, presenting as acute back pain, neuropathy, and spinal compression. Diagnosis is commonly based on identification of…
Abstract Number: 0695 • ACR Convergence 2020
Chronic Inflammatory Back Pain Occurring Later in Life: A Neglected Concept
Lauren Ridley¹, Nahid Rianon², Mark Hwang³, MinJae Lee⁴, Lianne Gensler⁵, Michael Ward⁶, Matthew Brown⁷, Amirali Tahanan², Mohammad Rahbar², Mariko Ishimori⁸, Michael Weisman⁹ and John Reveille¹⁰, ¹McGovern Medical School at UTHealth, Houston, TX, ²McGovern Medical School at UTHealth, Houston, ³McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, ⁴UT Southwestern, Dallas, ⁵University of California San Francisco, San Francisco, CA, ⁶National Institutes of Health, Bethesda, MD, ⁷Guy's and St Thomas, NHS Foundation Trust and King's College London NIHR Biomedical Research Centre, King's College London, London, United Kingdom, London, United Kingdom, ⁸Cedars-Sinai Medical Center, Los Angeles, CA, ⁹Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at UCLA, LOS ANGELES, CA, ¹⁰Department of Internal Medicine, University of Texas, Houston, TX
Background/Purpose: Chronic back pain (CBP) is a common musculoskeletal complaint and a significant cause of disability (Weisman et al., 2013). A subset of CBP, chronic…
Abstract Number: 0906 • ACR Convergence 2020
Bimekizumab Treatment Is Associated with Improvements in Back Pain and Fatigue in Patients with Active Psoriatic Arthritis: 48-Week Results from a Phase 2b Study
Atul Deodhar¹, Laure Gossec², Philip Mease³, Jason Coarse⁴, Heather Edens⁵, Natasha de Peyrecave⁶, Deepak Assudani⁶, Barbara Ink⁷ and Christopher Ritchlin⁸, ¹Oregon Health & Science University, Portland, OR, ²Sorbonne Université and Hôpital Universitaire Pitié Salpêtrière, Paris, France, ³Seattle Rheumatology Associates, P.L.L.C., Seattle, WA, ⁴UCB Pharma, Raleigh, NC, ⁵UCB Pharma, Smyrna, GA, ⁶UCB Pharma, Slough, United Kingdom, ⁷UCB Pharma, Slough, ⁸Department of Medicine, University of Rochester Medical Center, Rochester, NY
Background/Purpose: Patients (pts) with psoriatic arthritis (PsA) require effective treatment across all symptoms. Bimekizumab (BKZ) is a humanized IgG1 monoclonal antibody which selectively neutralizes interleukin…
Abstract Number: 0962 • ACR Convergence 2020
Efficacy of Clomipramine for Chronic Lumbar Radicular Pain a Randomized Clinical Trial
Saloua Afilal¹, Safaa Fellous¹, Ilham Aachari¹, Redouane Abouqal², Ihsane Hmamouchi³, Nada Alami¹, Latifa Tahiri¹, Hanan Rkain¹, Najia Hajjaj-Hassouni⁴ and Fadoua Allali¹, ¹Rheumatology B Department, El Ayachi Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat, Morocco., Rabat, Morocco, ²Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco., Rabat, Morocco, ³Temara Hospital, Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco, Rabat, Morocco, ⁴Health Sciences College, International University of Rabat (UIR), Rabat, Morocco
Background/Purpose: Lumbar radicular pain is the most common chronic neuropathic pain syndrome. Antidepressants are highly recommended for neuropathic pain, but there is no evidence for…
Abstract Number: 1183 • 2019 ACR/ARP Annual Meeting
Gout and Serum Urate Levels Are Associated with Lumbar Spine Monosodium Urate Deposition and Chronic Low Back Pain: A Dual-Energy CT Study
Michael Toprover¹, Anastasia Slobodnick ², Courtney Pike ³, Cheongeun Oh ⁴, Claudine Davis ², Michael Mechlin ⁵ and Michael H Pillinger ⁶, ¹Rheumatology Division, NYU Langone Health and Rheumatology Section, NY Harbor Health Care System, Department of Veterans Affairs., New York, NY, ²Rheumatology Division, NYU Langone Health, New York, ³Rheumatology Section, NY Harbor VA Healthcare System, New York, ⁴Biostatistics Department, NYU Langone Health, New York, ⁵Musculoskeletal Radiology, NYU Langone Health, New York, ⁶Rheumatology Division, NYU Langone Health and Rheumatology Section, NY Harbor Health Care System, Department of Veterans Affairs., New York
Background/Purpose: More than 130 cases of gout of the spine have been reported, with presenting symptoms including acute back pain, neuropathy, and spinal compression; diagnosis…
Abstract Number: 1231 • 2018 ACR/ARHP Annual Meeting
Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS
Jorge Juan Fragio Gil¹, Roxana Gonzalez Mazario¹, Francisco Miguel Ortiz-Sanjuán¹, Jose Ivorra Cortes¹, Elena Grau Garcia¹, Karla Arevalo¹, Isabel Martinez Cordellat¹, Inmaculada Chalmeta Verdejo¹, Jose Eloy Oller Rodriguez¹, Luis Gonzalez Puig¹, Marta De la Rubia Navarro¹, Rosa Negueroles Albuixech¹, Cristina Alcañiz Escandell², Elvira Vicens Bernabeu¹, Eva Calabuig³, Maria Tasias Pitarch³, Miguel Salavert Lleti³ and Jose Andres Roman Ivorra¹, ¹Rheumatology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, ²IIS La Fe, Valencia, Spain, ³Infectious Diseases Unit. Hospital Universitario y Politecnico La Fe, Valencia, Spain
Background/Purpose: Vertebral Osteomyelitis is an infectious disease of the vertebral body which could involve the intervertebral space (spondylodiscitis). Early diagnosis and treatment are essential in…
Abstract Number: 193 • 2017 ACR/ARHP Annual Meeting
Evaluation of a Diversionary Back Pain Service
Lynden Roberts, Rheumatology, Monash Medical Centre, Clayton, Australia
Background/Purpose: Surgical treatment of spinal pain is rarely indicated. Nevertheless, primary care clinician referrals to spinal surgeons for evaluation of spinal pain conditions are common.…
Abstract Number: 208 • 2017 ACR/ARHP Annual Meeting
Influence of Depression on Healthcare Expenditures Among Adults with Spondylosis, Intervertebral Disc Disorders and Other Back Problems in the United States
Jawad Bilal¹, Adam Berlinberg¹, Jaren Trost¹, Sandipan Bhattacharjee² and Irbaz Bin Riaz¹, ¹Banner University Medical Center, Tucson, AZ, ²Department of Pharmacy, University of Arizona, Tucson, AZ
Background/Purpose: Back pain is a very prevalent complaint affecting two-thirds of population, and accounts for 90.7 billion dollars annually in healthcare expenditure. The occurrence of…
Abstract Number: 307 • 2017 ACR/ARHP Annual Meeting
Biochemical Intervertebral Disc Alterations in Patients with Low Back Pain and Radiculopathy
Philipp Sewerin¹, Christoph Schleich², Ruben Sengewein³, Matthias Schneider⁴ and Benedikt Ostendorf¹, ¹Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Düsseldorf, Germany, ²Dep. for diagnostic and interventional Radiology, Heinrich-Heine University, Duesseldorf, Germany, ³Department and Hiller Research Unit for Rheumatology, Heinrich-Heine University, Düsseldorf, Germany, ⁴Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
Background/Purpose: To assess the glycosaminoglycan (GAG) content of lumbar intervertebral discs (IVD) in patients with low back pain (LBP) and radiculopathy using glycosaminoglycan chemical exchange…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].